MarketInOut Stock Screener Log In | Sign Up
 

Solasia Pharma KK

TSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/23/2026 15:30
Solasia Pharma KK stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeTSE
Market Capitalization7,917.15 mln
Float245 mln
Earnings Date08/18/2025

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-0.65
Highly suspicious

Relative Strength

8 / 100
Severely lagging

Debt / Equity

0.05
Debt-free

Pre-Tax Margin

-232%
Severely loss-making

ROE

-56.43
Deeply negative

Business Description

Solasia Pharma K.K. is a pharmaceutical company founded in 2006 and based in Minato, Japan, that sells and distributes medicines and medical devices across Japan, China, South Korea, and other markets. Its current lineup includes treatments for mouth sores caused by cancer therapy, a drug for a rare type of blood cancer, and a patch that helps patients manage nausea during chemotherapy. The company is also working on two early-stage treatments aimed at nerve damage and colorectal cancer caused by chemotherapy.

Key Fundamentals

EPS-3.29
ROE-56.43
RPS1.47
ROIC-240
ROA-44.00
Interest Cover-81.09
EBITDA, mln-856
EV / EBITDA-8.47
EV / EBIT-8.15
Revenue, mln388
EV / Revenue18.69

Quote Details

Last 27.00
Change 1 (3.85%)
Open 26.00
Volume 103,928,896
Turnover 2,806,080,256
Average Volume 72,875,464

Financial Ratios

Pre-Tax Profit Margin-232
Leverage Ratio1.31
Current Ratio4.28
Price / Book5.83
Price / Tangible Book5.83
Debt / Equity0.05
Price / Sales21.02

Financial Strength

Altman Z-Score10.04
Piotroski F-Score 5 / 9
Beneish M-Score-0.65

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0% 72 / 100   
1 Month -12.9% 11 / 100   
2 Months 0% 49 / 100   
6 Months -25% 9 / 100   
1 Year -22.86% 12 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog